Mr. Andre Audet reports

MOLECULE HOLDINGS INC. ANNOUNCES REVOCATION OF CEASE TRADE ORDER AND PROVIDES CORPORATE UPDATE

Molecule Holdings Inc. has received a revocation of the failure to file cease trade order (CTO) issued by the Ontario Securities Commission (OSC) on Oct. 5, 2023, which prohibited the trading by any person or company of any securities of the company in Canada, except pursuant to limited exceptions under the CTO.

The CTO was issued by the OSC as a result of the Company's failure to file its interim financial statements, management's discussion and analysis and related officer certifications for the three and nine months ended July 31, 2023 (collectively, the "Interim Filings") as required under Parts 4 and 5 of National Instrument 51-102 - Continuous Disclosure Obligations and pursuant to National Instrument 52-109 - Certification of Disclosure in Issuer's Annual and Interim Filings. The Company completed the filing of the Interim Filings on December 28, 2023 and are now available for review on SEDAR+ at www.sedarplus.ca.

With the revocation of the CTO, trading in the common shares of the Company through the facilities of the Canadian Securities Exchange (the "CSE") is expected to resume in the coming business days.

Corporate Update

The Company is also pleased to provide a general corporate update in furtherance of its press release dated October 6, 2023.

As a result of the issuance of the CTO, the Company was restricted from performing any acts in furtherance of a trade. Following the revocation of the CTO by the OSC, the Company now plans to re-engage in discussions with both the CSE and the holders of certain debentures issued by the Company (the "Holders") to amend the terms of such debentures in order to allow for conversion on terms satisfactory to the Company, the Holders, and the CSE. The Company also plans to re-initiate conversations with potential investors regarding a financing who had shown potential interest prior to the issuance of the CTO.

The Company believes that amendments of certain debentures, if approved by all relevant stakeholders, will assist the Company in reorganizing its capital structure in order to attract investment required to manage the growth of the business. However, at present, there can be no assurance as to what, if any, alternatives might be pursued by the Company. There can also be no assurance that the Company will reach any solution with the Holders and the CSE, the terms of any such solution, if achieved, or the completion of any financing.

About Molecule Holdings Inc.

Molecule is a licensed producer dedicated to creating cannabis-infused beverages for the Canadian market. We produce leading, top-quality drinks to provide opportunity and choice to people seeking a convenient and social way to consume cannabis. Molecule is focused on growing both our portfolio, and the overall cannabis beverage market. We want to ensure people have the best opportunity to find exactly the product and experience they thirst for.

We seek Safe Harbor.